Decouvor collaborates with multiple globally licensed biological laboratories to develop candidate therapeutics for medical responses to bioterrorism, including those targeting Bacillus anthracis and Yersinia pestis. We offer biosafety level BSL-2 (P2) and BSL-3 (P3) laboratory services.